Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe

News Update

TICKERS: RHT; RQHTF; A2AJTB

Tech Firm Releases Telemedicine Product Aiding Senior Care, Safety
News Update

Share on Stocktwits

Source:

The package encompasses wearable devices, two-way video communication and geofencing.

Reliq Health Technologies Inc. (RHT:TSX.V; RQHTF:OTCQB) announced in a news release it debuted a healthcare services product line, iUGO HOME, a complement to its already available iUGO CARE.

IUGO HOME encompasses wearable devices, specifically watches and pendants, along with two-way video communication and geofencing, use of a virtual perimeter for an actual geographic area. It also interfaces with the iUGO platform.

The software, developed "in response to repeated requests from our clients and potential clients," was designed for seniors aging at home or in some type of outside facility—skilling nursing, long term care, hospice or other, CEO Dr. Lisa Crossley said in the release.

The wearables serve as a personal emergency response system. In the case of users at home, the device would alert a call center in emergencies. The call center staff would then communicate live with the individual through two-way audio and video on the watch or pendant to assess him or her and situation, and provide instructions or seek emergency services if needed.

For users in a care facility, they may use the wearable device to communicate with staff from wherever they are on the premises, even the shower or outside, when they need help. Also, the device can alert staff if a resident wearing one falls.

Along with urgent situations, the iUGO HOME watch or pendant can deliver medication reminders. Further, it can track a person's whereabouts via GPS and alert care providers or family members if the he or she leaves a predefined, or geofenced, area.

[NLINSERT]

Disclosure:
1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: none. She or members of her household are paid by the following companies mentioned in this article: none.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees. As of the date of this article, an affiliate of Streetwise Reports has a consulting relationship with Reliq Health. Please click here for more information.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional, and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this interview, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of UGE International, a company mentioned in this article.





Want to read more about Healthcare Services investment ideas?
Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe